FTI Consulting FCN Q1 2026 Earnings EPS Misses Estimates but Stock Gains Sleep Number Q1 2026 Earnings Massive EPS Miss Amid Challenging Demand Environment Kiora Pharmaceuticals Q1 2026 Earnings EPS Beat Masks Continued PreRevenue Status as Stock Slips Accelerant Holdings Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction TLK Q4 2025 Earnings Significant EPS Miss Sends Shares Lower SYK Q1 2026 Earnings EPS Misses Estimates Shares Slide 226